Overview (26 Nov 2021)
AJANTA PHARMA LTD.
AJANTPHARM
INE031B01049

Pharmaceuticals
Result was last declared on 03 Nov 2020
3.8

Prev. Close
Previous Close
2088
Current Close
2091.8
Current High
2137.9
Current Low
2070
52 Week High
2365.8
52 Week Low
1510.1
Resistance 1
2129.80
Resistance 2
2167.80
Support 1
2061.90
Support 2
1994.00
Std Deviation
2.84%
DMA 200
1995.26
DMA 50
2183.54
DMA 20
2139.72
Fundamentals and Ratios
Standalone
Trailing EPS
77.59
Forwad EPS
84
Trailing P/E
26.96
Forward P/E
24.9
PEG Ratio
3.014
Mkt. Cap (Cr)
Market Cap (Cr)
18253.31
Total Debt(Cr)
Tot. Debt(Cr)
186.10
Reserve (Cr)
2581.33
Book Value
300.45
P/BV Ratio
6.96
ROCE(%)
33.00
ROE
36.00
Consolidated
Trailing EPS
75.09
Forwad EPS
81.49
Trailing P/E
27.86
Forward P/E
25.67
PEG Ratio
3.01
Mkt. Cap (Cr)
Market Cap (Cr)
18253.31
Total Debt(Cr)
Tot. Debt(Cr)
186.10
Reserve (Cr)
2581.33
Book Value
300.45
P/BV Ratio
6.96
ROCE(%)
33.00
ROE
36.00

 

Financial Result
Standalone
TypeSep-21Jun-21Mar-21Dec-20Sep-20FY20-21
Revenue823.71742.72748.07733.16676.512718.59
Other Income52.4131.001.332.9086.24103.57
Total Income876.12773.72749.40736.06762.752822.16
Interest0.071.172.182.171.356.90
Expenditure-621.33-540.63-532.65-517.72-454.22-1920.07
PBDT0.000.000.000.000.000.00
Depreciation-30.40-29.76-29.48-27.95-27.20-111.49
PBT254.79233.09216.75218.34308.53902.09
Tax-57.94-39.63-61.97-38.39-83.31-226.45
Equity0.000.000.000.000.000.00
OPM30.9331.3828.9729.7845.6132.00
Net Profit196.85193.46154.78179.95225.22675.64
NPM23.926.0520.6924.5433.2924
EPS22.7522.3617.8920.825.8177.59
Consolidated
TypeSep-21Jun-21Mar-21Dec-20Sep-20FY20-21
Revenue884.8747.99756.84748.74715.912889.69
Other Income29.5432.632.535.484.8525.98
Total Income914.34780.62759.37754.22720.762915.67
Interest0.401.512.562.551.538.27
Expenditure-653.92-560.17-530.59-538.75-471.52-2015.49
PBDT0.000.000.000.000.000.00
Depreciation-31.54-30.88-30.60-29.14-28.33-116.09
PBT260.42220.45228.78215.47249.24900.18
Tax-64.48-46.70-69.52-38.84-79.02-246.31
Equity0.000.000.000.000.000.00
OPM28.4828.2430.1328.5734.5830.87
Net Profit195.94173.75159.26176.63170.22653.87
NPM21.4322.2620.9723.4223.6222.43
EPS22.6420.0818.420.4119.5175.09
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2021Interim Divvidend9.50Interim Dividend - Rs. - 9.500012 Nov 2020
2020Interim Divvidend13.00Interim Dividend - Rs. - 13.000015 Nov 2019
2019Interim Divvidend9.00Interim Dividend - Rs. - 9.000009 Nov 2018
2017Interim Divvidend7.00Interim Dividend - Rs. - 7.000023 Mar 2017
2017Interim Divvidend6.00Interim Dividend - Rs. - 6.000007 Nov 2016
2016Interim Divvidend8.00Interim Dividend - Rs. - 8.000017 Mar 2016
2015Final Dividend6.00Dividend - Rs. - 6.000025 Jun 2015
2014Final Dividend10.00Dividend - Rs. - 10.000024 Jul 2014
2013Final Dividend6.25Dividend - Rs. - 6.250018 Jul 2013
2012Final Dividend7.50Dividend - Rs. - 7.500028 Jun 2012
2011Final Dividend5.00Dividend - Rs. - 5.000023 Jun 2011
2010Final Dividend3.50Dividend - Rs. - 3.500029 Jun 2010
2009Final Dividend2.50Dividend - Rs. - 2.500030 Jun 2009
2008Final Dividend2.50Dividend - Rs. - 2.500027 Jun 2008
Bonus
YearRatioRemarkEx Date
20131:2Bonus issue 1:217 Sep 2013
Split
YearRatioRemarkEx Date
2015Rs.5/- to Rs.2/-Stock Split From Rs.5/- to Rs.2/-20 Mar 2015
2012Rs.10/- to Rs.5/-Stock Split From Rs.10/- to Rs.5/-09 Aug 2012
Sector: Pharmaceuticals
CompanyCurrent CloseP/E Ratio
AARTIDRUGS
516.1
18.67
ABBOTINDIA
19581.2
60.24
AJANTPHARM
2091.8
26.96
ALBERTDAVD
593.05
15.28
ALEMBICLTD
102.65
197.4
ALKEM
3562.9
25.28
AMBALALSA
29.5
-24.18
ANUHPHR
105.5
18.57
APLLTD
796.6
13.13
AREYDRG
37.2
13.33
ARMOURPO
183.75
20.93
ASTRAZEN
3180.85
85.23
AUROLAB
102.3
8.88
AUROPHARMA
678.55
12.77
BACPHAR
4.75
-11.59
123456789
Connect @
Important Links
BSE
NSE
Copyright: IndiaOne Media 2020